Register for a live broadcast to learn more about TRODELVY (sacituzumab govitecan-hziy) with Dr. Hope S. Rugo

<< View All Contributors

Beth Eaby-Sandy, MSN, CRNP

Beth Eaby-Sandy is a thoracic oncology nurse practitioner in the Abramson Cancer Center at the University of Pennsylvania. She speaks nationally on the topics of lung cancer and supportive care including chemotherapy-induced nausea and vomiting, and the management of adverse events from targeted therapies and immunotherapy used in lung cancer. Beth also edits several peer-reviewed oncology journals and book chapters. She is an active member of the International Association for the Study of Lung Cancer and serves on its Nursing and Allied Health committee.
The 2nd Annual School of Nursing Oncology™, held in Chicago on August 3-4, offered educational opportunities in a fun and exciting setting for oncology nurses.
12:22 PM, Tue August 21, 2018
External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.